Craniodiaphyseal dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1513OMIM:122860M85.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Craniodiaphyseal dysplasia (CDD) is an extremely rare skeletal disorder characterized by massive generalized hyperostosis and sclerosis of the skull and facial bones, along with sclerosis and hyperostosis of the diaphyses (shafts) of long bones. The condition leads to progressive thickening and distortion of the craniofacial bones, resulting in a dramatically altered facial appearance sometimes described as 'leontiasis ossea' (lion-like facies). The excessive bone growth in the skull can cause narrowing and obstruction of cranial foramina, leading to serious complications including compression of cranial nerves, which may result in facial palsy, hearing loss, visual impairment, and even blindness. Obstruction of the nasal passages and paranasal sinuses is common, causing breathing difficulties. Increased intracranial pressure may also develop due to reduced intracranial space. The condition typically manifests in early infancy or childhood, with progressive facial distortion and neurological complications worsening over time. Affected individuals may also exhibit wide nasal bridge, hypertelorism (widely spaced eyes), and mandibular enlargement. The long bones show cortical thickening and diaphyseal sclerosis, though the epiphyses are generally spared. Intellectual development may be affected in some cases due to increased intracranial pressure. There is currently no cure for craniodiaphyseal dysplasia. Treatment is primarily supportive and symptomatic. Surgical intervention may be attempted to decompress cranial nerves, relieve nasal obstruction, or reduce intracranial pressure, but bone regrowth after surgery is common and outcomes are often limited. Repeated surgical procedures may be necessary. The prognosis is generally poor, with many patients experiencing significant morbidity from progressive cranial nerve compression and potential life-threatening complications. Both autosomal dominant and autosomal recessive forms have been described, with the autosomal dominant form being more commonly reported in the literature.

Clinical phenotype terms— hover any for plain English:

Stenosis of the external auditory canalHP:0000402Craniofacial hyperostosisHP:0004493Diaphyseal undertubulationHP:0005019
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Craniodiaphyseal dysplasia.

View clinical trials →

No actively recruiting trials found for Craniodiaphyseal dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Craniodiaphyseal dysplasia community →

No specialists are currently listed for Craniodiaphyseal dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Craniodiaphyseal dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Craniodiaphyseal dysplasiaForum →

No community posts yet. Be the first to share your experience with Craniodiaphyseal dysplasia.

Start the conversation →

Latest news about Craniodiaphyseal dysplasia

No recent news articles for Craniodiaphyseal dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Craniodiaphyseal dysplasia

What is Craniodiaphyseal dysplasia?

Craniodiaphyseal dysplasia (CDD) is an extremely rare skeletal disorder characterized by massive generalized hyperostosis and sclerosis of the skull and facial bones, along with sclerosis and hyperostosis of the diaphyses (shafts) of long bones. The condition leads to progressive thickening and distortion of the craniofacial bones, resulting in a dramatically altered facial appearance sometimes described as 'leontiasis ossea' (lion-like facies). The excessive bone growth in the skull can cause narrowing and obstruction of cranial foramina, leading to serious complications including compression

At what age does Craniodiaphyseal dysplasia typically begin?

Typical onset of Craniodiaphyseal dysplasia is infantile. Age of onset can vary across affected individuals.